EUVIMEDEUVIMED entdecken
Crossref

289 Therapeutic Potential of MY004, an IRAK4 Inhibitor, in Psoriasis: Preclinical Activity and Molecular Mechanism

Ying He, Keyu Xu, Yufei Xiong, Wei Li

Journal of Investigative Dermatology · 2025-11 · 145 (11) · e77

DOI: 10.1016/j.jid.2025.09.293 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2025-11. Verfasst von Ying He und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

He, Y., Xu, K., Xiong, Y., & Li, W. (2025). 289 Therapeutic Potential of MY004, an IRAK4 Inhibitor, in Psoriasis: Preclinical Activity and Molecular Mechanism. Journal of Investigative Dermatology, 145(11), e77. https://doi.org/10.1016/j.jid.2025.09.293

Vancouver

He Y, Xu K, Xiong Y, Li W. 289 Therapeutic Potential of MY004, an IRAK4 Inhibitor, in Psoriasis: Preclinical Activity and Molecular Mechanism. Journal of Investigative Dermatology. 2025;145(11):e77. doi:10.1016/j.jid.2025.09.293

BibTeX
@article{He2025,
  author = {He, Ying and Xu, Keyu and Xiong, Yufei and Li, Wei},
  title = {289 Therapeutic Potential of MY004, an IRAK4 Inhibitor, in Psoriasis: Preclinical Activity and Molecular Mechanism},
  journal = {Journal of Investigative Dermatology},
  year = {2025},
  volume = {145},
  number = {11},
  pages = {e77},
  doi = {10.1016/j.jid.2025.09.293}
}
Kostenlos starten →